Spectral AI

Regulatory Pressures Will Stifle Growth Despite Nascent Market Improvements

AnalystLowTarget

Not Invested

Consensus Narrative from 5 Analysts

Published

29 Aug 25

AnalystLowTarget's Fair Value

US$3.50

48.0% undervalued

04 Sep

US$1.82

35.8%

-5.7%

35.8%

-5.7%

Edit anytime before Aug 29 10:16 PM. Then post Updates to your followers.

Author's Valuation

US$3.5

48.0% undervalued

AnalystLowTarget Fair Value

Narrative

Updates0

AnalystLowTarget Fair Value

US$3.5

48.0% undervalued

Future estimation in

% p.a.

Decrease

Increase

Current revenue growth rate

16.64%

Medical Equipment revenue growth rate

0.43%

Risk Level (Discount Rate)

Our default considers factors like the company's size, volatility, profitablity and country of operation.

Decrease

Increase

Current discount rate

7.81%

Calculation

US$1.20m

Earnings '28

215.59x

PE Ratio '28

US$258.05m

Market Cap '28

US$258.05m

Market Cap '28

58.73m

No. shares '28

US$4.39

Share Price '28

US$4.39 Share Price '28

Discounted to 2025 @ 7.88% p.a.

US$3.50

Fair Value '25